Cygenex

Cygenex is a precision medicine company leveraging genetic data to help clients make smarter healthcare decisions and save money. The company utilizes the latest in genetic testing to manage member populations through risk assessment, genomic sequencing, and event cycling. By bringing key players into the healthcare continuum, Cygenex aims to build member rapport, improve outcomes, reduce risk, and significantly lower healthcare spend. Genetic testing is a crucial component of today's healthcare delivery system, enabling prevention, early detection, and personalized treatment of diseases. It allows for the use of the most effective treatment options, minimizes dangerous drug side effects, and promotes healthier lifestyles while reducing healthcare costs. Cygenex serves administrators, brokers, and self-funded health plans striving to provide quality care while controlling costs. The company offers cost-effective solutions and a "patent pending" precision medicine tool to align with initiatives for cost control. By incorporating a risk assignment method and an event cycling process, Cygenex engages members, providers, and pharmacies based on genetic findings, ultimately resulting in significant cost savings. Founded in 2021, Cygenex operates in the Analytics, Health and Wellness, and Sports industries. Currently, there is no publicly disclosed information about the company's headquarter location or its last investment and investors.